Clinical Trials List
2010-11-01 - 2013-12-31
Phase III
Terminated6
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wen-Chung Yu Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
- Harn-Shen Chen Division of Endocrinology
- Po-Hsun Huang Division of Cardiovascular Diseases
- Ju-Pin Pan Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- Kang-Ling Wang Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- - - Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊宜瑱 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
90 participants
-
Global
6000 participants
